FDA Inspection 1197253 — Versiti Illinois, Inc.
The FDA completed an inspection of Versiti Illinois, Inc. on February 3, 2023 in Winfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 3, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Winfield, IL (United States)